CIM
ELV icon

Contrarius Investment Management’s Elevance Health ELV Stock Holding History

Contrarius Investment Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-66,447
Closed -$5.56M – 33
2013
Q3 		$5.56M Sell
66,447
-1,405
-2% -$120K 0.5% 27
2013
Q2 		$5.55M Buy
+67,852
New +$5.08M 0.61% 22

Other funds holding ELV

Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Contrarius Investment Management's ELV Position: Q4 2013 in Review

Contrarius Investment Management sold out of Elevance Health (ELV) in Q4 2013, closing a stake of 66,447 shares — an estimated $5.56M sold.

Contrarius Investment Management first reported a position in ELV in Q2 2013 and held it in 2 quarters. The position peaked at $5.56M in Q3 2013. 639 funds tracked by Wall St. Rank hold ELV as of Q4 2013.

  • Contrarius Investment Management reported no remaining Elevance Health position as of Q4 2013 after selling out during the quarter.
  • Contrarius Investment Management sold 66,447 Elevance Health shares in Q4 2013, an estimated $5.56M.
  • Contrarius Investment Management first reported a position in Elevance Health in Q2 2013 and held it in 2 quarters.
  • Contrarius Investment Management's Elevance Health position peaked at $5.56M in Q3 2013.
  • 639 funds tracked by Wall St. Rank held Elevance Health as of Q4 2013.

Based on Contrarius Investment Management's 13F filing for Q4 2013, filed 13 Feb 2014.